Additionally, GPR4 overexpression promotes the development of osteoarthritis (OA), and the pharmacological inhibition of GPR4 protects mice against OA via regulating the CXCL12/CXCR7 pathway [44]. The gene discussed is GPR4; the disease is osteoarthritis.